New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 5, 2012
18:38 EDTFNSR, ALGN, VRA, AMBA, DCTH, DHIL, ASNA, ELX, MW, GRMNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Finisar (FNSR), up 6%... Ascena Retail (ASNA), up 2%... Ambarella (AMBA), up 1.5%... ALSO HIGHER: Garmin (GRMN), up 4% after being added to S&P 500, effective December 11 close... Diamond Hill Investment Group (DHIL), up 5% after announcing $8 per share special dividend... DOWN AFTER EARNINGS: Vera Bradley (VRA), down 9%... Men's Warehouse (MW), down 8% after earnings and lowered guidance... ALSO LOWER: Delcath Systems (DCTH), down 11% after announcing a modified NDA with the FDA... Align Technology (ALGN), down 4% after saying it sees EPS, revenue at lower end of previous guidance... Emulex (ELX), down 3% after announcing acquisition, reaffirming previous guidance.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 30, 2015
07:31 EDTGRMNGarmin to open brick-and-mortar stores in greater Miami area
Subscribe for More Information
06:30 EDTGRMNGarmin downgraded to Underweight from Neutral at JPMorgan
Subscribe for More Information
July 29, 2015
12:51 EDTAMBAAmbarella calls active after mentioned cautious by Citron Research
Ambarella July weekly 118 and 129 calls are active on total call volume of 11K contracts (8K) puts after mentioned cautious by Citron Research. July weekly call option implied volatility is at 75, August is at 64, September is at 67; compared to its 52-week range of 43 to 72. Active options volume suggests traders taking positions for price movement.
11:13 EDTAMBAAmbarella will trade back to $90, Citron Research says
Short selling blog Citron Research issued a new report on Ambarella (AMBA), saying the stock will trade back to $90 "on its way to much lower." The semiconductor company designed into GoPro (GPRO) cameras is trading down $2.82 to $116.44 in morning trading. Reference Link
11:10 EDTAMBAAmbarella mentioned cautious by Citron Research
Subscribe for More Information
10:50 EDTGRMNGarmin says underlying foundation is 'solid', sees long-term growth in Aircraft
Subscribe for More Information
07:04 EDTGRMNGarmin sees FY15 pro forma EPS about $2.65, consensus $2.78
Subscribe for More Information
07:03 EDTGRMNGarmin reports Q2 EPS 72c, consensus 80c
Subscribe for More Information
July 28, 2015
15:21 EDTGRMNNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include MasterCard (MA), consensus 85c... Altria (MO), consensus 71... General Dynamics (GD), consensus $2.06... Anthem (ANTM), consensus $2.75... Praxair (PX), consensus $1.46... Northrop Grumman (NOC), consensus $2.36... McKesson (MCK), consensus $2.91... Eaton (ETN), consensus $1.13... Humana (HUM), consensus $1.63... Hilton (HLT), consensus 23c... International Paper (IP), consensus 92c... Rockwell Automation (ROK), consensus $1.54... Jarden (JAH), consensus 59c... Quintiles (Q), consensus 70c... Tableau Software (DATA), consensus 4c... Garmin (GRMN), consensus 82c... Vantiv (VNTV), consensus 54c... ADT (ADT), consensus 49c.
10:07 EDTVRAHigh option volume stocks
Subscribe for More Information
July 27, 2015
17:03 EDTDCTHMitchell Kopin reports 6.7% passive stake in Delcath Systems
09:36 EDTAMBAActive equity options trading on open
Active equity options trading on open: AAPL NFLX INTC MU VZ BIDU AMBA
July 23, 2015
19:06 EDTALGNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Amazon (AMZN), up 17.2%... Marketo (MKTO), up 15.4%... Juniper Networks (JNPR), up 9.9%... NetGear (NTGR), up 9.2%... Qlik Technologies (QLIK), up 9.1%... LogMeIn (LOGM), up 9.9%... Pandora (P), up 10.3%... Mitek Systems (MITK), up 7.8%... Proofpoint (PFPT), up 5.1%... Supreme Industries (STS), up 4.7%... Skyworks (SWKS), up 3.6%... IGI Laboratories (IG), up 3.7%... Maxim Integrated Products (MXIM), up 4.1%... Boyd Gaming (BYD), up 4.1%... Trinity Industries (TRN), up 5%... Trinity Industries (N), up 3.2%... Starbucks (SBUX), up 4.5%. ALSO HIGHER: Qorvo (QRVO), up 2.7% after Skyworks reported quarterly results. DOWN AFTER EARNINGS: TrueCar (TRUE), down 33.1% after reporting quarterly results and cutting fiscal 2015 revenue guidance... Tripadvisor (TRIP), down 9.2%... Align Technology (ALGN), down 7.4%... Capital One (COF), down 4.9%... PMC-Sierra (PMCS), down 9.1%... athenahealth (ATHN), down 2.1%. ALSO LOWER: Sunesis Pharmaceuticals (SNSS), down 59.7% after giving vosaroxin regulatory update... Avalanche Biotechnologies (AAVL), down 5.6% after CEO Thomas Chalberg, Jr., Ph.D. resigns and Hans Hull name interim CEO.
16:09 EDTALGNAlign Technology restructures leadership structure under CEO
Align Technology is simplifying the commercial reporting structure for its three key regions and global marketing. Under this new structure, North America, EMEA, and Asia Pacific sales organizations will come together under the leadership of CEO Joe Hogan. Raphael S. Pascaud, previously Align's vice president, international, has been promoted to chief marketing portfolio and business development officer. Pascaud's new role will consolidate leadership of the global marketing and business development functions for the xompany. Tim Mack, previously vice president, business development, will continue to report to Hogan focusing exclusively on Align's scanner business as vice president, scanner and services. John Graham, Align's CMO, will leave the company effective July 23 for other opportunities.
16:06 EDTALGNAlign Technology sees Q3 EPS 28c-31c, consensus 45c
Subscribe for More Information
16:02 EDTALGNAlign Technology reports Q2 EPS 39c, consensus 37c
Subscribe for More Information
14:27 EDTASNAAscena Retail management to meet with SunTrust
Subscribe for More Information
10:05 EDTALGNHigh option volume stocks
Subscribe for More Information
07:43 EDTASNAStephens to hold a tour
Subscribe for More Information
July 20, 2015
08:07 EDTDCTHDelcath Systems's melphalan granted Orphan Drug Designation by FDA
Delcath Systems announced that the FDA Office of Orphan Products Development, or OOPD, has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma. The OOPD is tasked with evaluating the scientific and clinical data submissions from sponsors to identify and designate products as promising for rare diseases and to further advance scientific development of such promising medical products.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use